Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion type Assertion NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_head.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion description "[In addition, antigen-specific CD4+ T cells from hybrid peptide immunized DR4-IE Tg mice synergized with HER-2/neu(435-443)-specific CD8+ T cells from HLA-A2.1 Tg HHD (H-2b) mice in producing antitumor immunity into SCID mice xenografted with the HER-2/neu+, HLA-A2.1+ and HLA-DR4+ FM3 human melanoma cell line.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_provenance.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion evidence source_evidence_literature NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_provenance.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion SIO_000772 17634957 NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_provenance.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion wasDerivedFrom befree-2016 NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_provenance.
- NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_assertion wasGeneratedBy ECO_0000203 NP620344.RAeWYQc76zNYNnY6HmM1P05P_35veTeG9_ayg9hfW3L0Y130_provenance.